Innovation Pharmaceuticals Inc (IPIX)

[GreenBioAnalyst]

I have no doubt that IPIX will go parabolic. The company 's mc is 30mc. That's very cheap! Brilacidin will be good for CV19 in all phases of patients, IMO. The upregulation of hdm in human epithelial cells, more so in human clinical trials will prove substantially beneficial in dampening the cytokine and chemokine storm induced by the virus in alveolar type II cells in the lungs for patients with severe and critically ill patients, with or without pneumonia. This drug does both. Activate innate followed by adaptive immune response by also reducing RANTES via induction of IFN-b( IFN-beta).

Cydy's leronlimab appreciated $1b on cv19 alone, and that is without funding. Now imagine what Ipix can do when the results are released! Over 350m mc easily, and that's over $1. Parasites and the criminal didn't get the memo.